drugset / Trial / NCT00914693

EU/LA Pearl Index Study - Transdermal Contraceptive Patch

NCT00914693

Phase 3 Completed 1694 enrolled Bayer
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The aim of the present study is to prove efficacy and safety of a new contraceptive patch.

Timeline

Start
2009-04
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 2.1 mg Other
Subject ethinyl estradiol Small molecule 0.55 mg Other

Indications

No indication recorded.